A dermal filler safety plan to ask for before treatment

Name the product and placement

Ask for the exact filler name, the planned treatment area, and the product information. FDA-approved fillers have specific indications and patient labeling. Tell the clinician about prior filler and relevant medical history so the proposed treatment can be evaluated for you. A familiar brand name or a social-media photo is not enough to establish that a product or placement is appropriate.

Sources: FDA: Dermal fillers (opens in a new tab)

Know the ordinary and the urgent

Swelling, bruising, tenderness, and redness can occur after filler. The FDA also warns that unintended injection into a blood vessel can cause serious harm. Ask the practice to distinguish expected short-term effects from symptoms that need an urgent response, and to provide that guidance in writing. Do not rely on an online timeline to decide that an unexpected symptom is harmless.

Sources: FDA: Dermal fillers (opens in a new tab) · FDA: Dermal filler dos and don’ts (opens in a new tab)

Recognize the FDA warning signs

The FDA advises immediate medical attention for unusual pain, vision changes, skin that appears white, gray, or blue near the injection site, or signs of a stroke during or shortly after filler injection. These examples are not a complete diagnostic list. If something concerning occurs, follow the treating practice’s emergency directions or seek urgent medical care; a website cannot examine or triage your symptoms.

Sources: FDA: Dermal filler dos and don’ts (opens in a new tab)

Ask what happens if a problem occurs

Before treatment, ask who can assess you urgently, how you reach that person after hours, and which emergency services the practice would use. Ask what supplies and referral arrangements it has for filler complications, with the answer tailored to the product proposed. The plan should be specific enough that you know whom to call and where to go. Save those instructions before leaving the appointment.

Avoid needle-free filler devices

The FDA warns against needle-free devices for dermal filler injection and against buying filler sold directly to the public. Ask whether the product comes through an appropriate medical channel and is opened for your procedure. A “painless” marketing claim does not remove the need for an identified licensed clinician, product information, consent, and a complication plan.

Sources: FDA: Dermal filler dos and don’ts (opens in a new tab)

Prepare for a useful consent discussion

Bring a list of medications and prior cosmetic procedures, including past filler whose product name you know. Ask about allergies, infection or inflammation near the area, and any history that might change the plan. Request the expected number of visits, full cost, written aftercare, and follow-up schedule. If you do not understand a risk or a suggested placement, pause before signing.

Keep the handoff clear

Record the treatment date, clinician, product, area, and instructions you receive. If the practice introduces another provider or location later, verify who is responsible for your care and how records would be shared. Glow Match Texas is an independent guide and has no verified treatment partner at this review stage; it cannot provide medical follow-up or emergency care.

What should written aftercare tell me?

It should identify the practice’s contact number, when follow-up is expected, which effects the clinician expects, and which symptoms need urgent assessment. Ask whom to contact after hours and whether the practice wants you to call it, seek emergency care, or both for a serious concern. Keep the sheet and the product record where you can find them later. Instructions should come from the treating practice and reflect the actual product and area.

Can every filler be handled the same way?

No. Fillers are made from different materials, and complication management depends on the product and the problem. Ask the clinician how the exact product proposed affects their emergency plan and whether it can be reversed or removed. Avoid assuming that a treatment described online for one material would apply to another. The FDA’s product information and the clinician’s plan should be specific to what is actually injected.

Sources: FDA: Dermal fillers (opens in a new tab)